Overcoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, MD, DMSc
Michael Böhm, MD, FESC
Luca De Nicola, MD, PhD
Ultrasound Renal Denervation: Interdisciplinary Approach to Better Patient Outcomes
Naomi Fisher, MD
Florian Rader, MD
Why We Should Be PRO Patients With CKD-Associated Pruritus
Lucio Manenti, MD, PhD
Jeanette Finderup, PhD, MHR, RN
Sebastian Koball, MD
Exploring Developments in IgAN and FSGS
Howard Trachtman, MD, FASN
Richard Lafayette, MD, FACP
PROTECT Study in IgAN: Topline Data
Jonathan Barratt, MD
Hyperkalemia in CKD and HFrEF…What Am I Missing?
George Bakris
David Bushinsky, MD
Lars Lund, MD
A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases
Antoni Bayés-Genís, MD, PhD, FESC, FHFA
Patrick Rossignol, MD, PhD
Achieving Success in IgAN & FSGS
Siân Griffin, MD, PhD
Jürgen Floege, MD
Loreto Gesualdo, MD, FERA
Directed Relief in CKD-aP: Linking Targeted Therapy to Clinical Outcomes
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Can We Do Better in IgAN?
Jonathan Barratt, PhD
Annette Bruchfeld, MD, PhD
KALMing the Itch: Improving QoL in Patients with CKD-aP
Joel Topf, MD
Kieran McCafferty, MD
Understanding IgAN & FSGS: Pathophysiology and Emerging Therapies
Donald E. Kohan, MD, PhD
Separating Fact from Fiction: The Realities of CKD-aP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Antoine Lanot, MD, PhD
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Mario Cozzolino, MD, PhD
Jan T. Kielstein, MD, FASN, FERA
Case-Based Management of AAV
David Jayne, MD